These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12678225)

  • 1. Developments in reduction and replacement of in vivo toxicity and potency tests for pertussis vaccines.
    Xing D; Canthaboo C; Douglas-Bardsley A; Yuen CT; Prior S; Liu Y; Corbel M
    Dev Biol (Basel); 2002; 111():57-68. PubMed ID: 12678225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C; Xing D; Corbel M
    Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in pertussis vaccines leading to reduction and replacement of in vivo testing.
    Redhead K
    Dev Biol Stand; 1996; 86():263-70. PubMed ID: 8785955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
    Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
    Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.
    van der Ark A; van Straaten-van de Kappelle I; Olander RM; Enssle K; Jadhav S; van de Donk H; Hendriksen C
    Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved protocols for histamine sensitization testing of acellular pertussis vaccines.
    Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY
    Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays.
    Xing D; Markey K; Das RG; Feavers I
    Expert Rev Vaccines; 2014 Oct; 13(10):1175-82. PubMed ID: 25182836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity.
    Mills KH; Brady M; Ryan E; Mahon BP
    Dev Biol Stand; 1998; 95():31-41. PubMed ID: 9855412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccines.
    Yuen CT; Horiuchi Y; Asokanathan C; Cook S; Douglas-Bardsley A; Ochiai M; Corbel M; Xing D
    Vaccine; 2010 May; 28(21):3714-21. PubMed ID: 20307594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency assay and characterization of lymphocytosis promoting factor in whole cell and acellular pertussis vaccines.
    Tiru M; Falk A; Brym-Grynblat B; Pettersson IM
    Dev Biol Stand; 1991; 73():157-65. PubMed ID: 1778309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a carbohydrate binding assay for the B-oligomer of pertussis toxin and toxoid.
    Gomez SR; Xing DK; Corbel MJ; Coote J; Parton R; Yuen CT
    Anal Biochem; 2006 Sep; 356(2):244-53. PubMed ID: 16782039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and immunogenicity of pertussis whole cell vaccine in one animal model.
    van Straaten I; Levels L; van der Ark A; Thalen M; Hendriksen C
    Dev Biol (Basel); 2002; 111():47-55. PubMed ID: 12678224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
    Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
    Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.